• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ACT:GR

94.144 EUR 2.064 2.24%

As of 04:55:19 ET on 08/29/2014.

Snapshot for Actelion Ltd (ACT)

Open: 92.210 Day's Range: 91.740 - 94.144 Volume: 60
Previous Close: 92.080 52wk Range: 47.962 - 95.500 1-Yr Rtn: +85.96%

Stock Chart for ACT

No chart data available.
  • ACT:GR 93.980
  • 1D
  • 1M
  • 1Y
92.080
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 21.0066
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) 5.2670
Est. PEG Ratio 1.9472
Market Cap (M EUR) 10,471.28
Shares Outstanding (M) 114.13
30 Day Average Volume 788
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.07%
Cash Dividend (CHF) 1.2000
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.

Jean-Paul ClozelCEO/Co-FounderAndre C MullerChief Financial Officer
Otto SchwarzExec VP/COOGuy BraunsteinExec VP/Head:Clinical Dev
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil